Researchers at Johns Hopkins have discovered a highly targeted anti-cancer drug, of a type they call a "prodrug." The obvious need for such therapies is clear.
The technology takes clever advantage of known properties of cancerous versus noncancerous cells to deliver meds to tumor cells while avoiding healthy cells which would otherwise be harmed.
Medicalxpress.com has the report. Hat tip to Instapundit for the link.
